submit urlsubmit rss feedadd directoryphysician directoryPharmacology opportunity

article

Astemizole (marketed under the brand name Hismanal) is a second generation antihistamine drug which has a long duration of action. It has been withdrawn from the market in most countries because of rare but potentially fatal interactions with CYP34A enzyme inhibitors.

Pharmacology


Astemizole is an histamine H1-receptor antagonist. It is structurally similar to terfenadine and haloperidol (a butyrophenone antipsychotic). It has anticholinergic and antipruritic effects.

Astemizole competitively binds to histamine H1-receptor sites in the gastrointestinal tract, uterus, blood vessels, and bronchial muscle. This suppresses the formation of edema and pruritus (caused by histamine).

More on [ Astemizole ]


directory of related categories

 
directory of related sites

Hismanal Withdrawn - Federal Register Aug. 22, 1999 relating to the withdrawal of Hismanal (astemizole) 10mg tablets from the US market (PDF)

Astemizole related videos
The 13-metal medal - Periodic Table of Videos
Next Video
Astemizole related videos

 

HOMEADVERTISINGABOUT US

articlesartsbusinesscomputersgameshealthhospitalshomekids & teensnewsmobilephysiciansrecreationreferenceregionalscienceshoppingsocietysportsworld


Submit a Site About Become an Editor